summary: This paper shows that celecoxib, a COX-2 inhibitor, inhibited the inflammatory response in a mouse model of MS, and concludes that celecoxib may be a potential therapeutic agent in MS.

authors: Miyamoto K, Miyake S, Mizuno M, Oka N, Kusunoki S, Yamamura T.

source: Brain. 2006 Aug;129(Pt 8):1984-92. Epub 2006 Jul 10

weblink: click here

category: Clinical Trials and Therapeutics

related research news: click here

glossary: